These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25488753)

  • 1. Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.
    Brugière O; Thabut G; Krawice-Radanne I; Rizzo R; Dauriat G; Danel C; Suberbielle C; Mal H; Stern M; Schilte C; Pretolani M; Carosella ED; Rouas-Freiss N
    Am J Transplant; 2015 Feb; 15(2):461-71. PubMed ID: 25488753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-G*01:04∼UTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation.
    Di Cristofaro J; Reynaud-Gaubert M; Carlini F; Roubertoux P; Loundou A; Basire A; Frassati C; Thomas P; Gomez C; Picard C
    Am J Transplant; 2015 Sep; 15(9):2413-20. PubMed ID: 25989360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation.
    White SR; Floreth T; Liao C; Bhorade SM
    PLoS One; 2014; 9(7):e103643. PubMed ID: 25068264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
    Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
    Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Vesicular-bound HLA-G as Noninvasive Predictive Biomarker of CLAD After Lung Transplantation.
    Brugière O; Dreyfuss D; Guilet R; Rong S; Hirschi S; Renaud-Picard B; Reynaud-Gaubert M; Coiffard B; Bunel V; Messika J; Demant X; Le Pavec J; Dauriat G; Saint Raymond C; Falque L; Mornex JF; Tissot A; Lair D; Le Borgne Krams A; Bousseau V; Magnan A; Picard C; Roux A; Glorion M; Carmagnat M; Gazeau F; Aubertin K; Carosella E; Vallée A; Landais C; Rouas-Freiss N; LeMaoult J;
    Transplantation; 2024 Sep; ():. PubMed ID: 39294868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
    Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
    Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
    Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
    Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Plasma Levels of Soluble HLA-G and HLA-G Genotypes in Kidney Transplant Recipients.
    Piancatelli D; Maccarone D; Colanardi A; Sebastiani P; D'Anselmi F; Iesari S; Binda B; Pisani F
    Transplant Proc; 2020 Jun; 52(5):1559-1561. PubMed ID: 32217007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA Mismatching Favoring Host-Versus-Graft NK Cell Activity Via KIR3DL1 Is Associated With Improved Outcomes Following Lung Transplantation.
    Greenland JR; Sun H; Calabrese D; Chong T; Singer JP; Kukreja J; Hays SR; Golden JA; Caughey GH; Venstrom JM; Rajalingam R
    Am J Transplant; 2017 Aug; 17(8):2192-2199. PubMed ID: 28375571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor human leukocyte antigen-G single nucleotide polymorphisms are associated with post-lung transplant mortality.
    Lazarte J; Ma J; Martinu T; Levy L; Klement W; White M; Pelling J; Guan Z; Azad S; Tikkanen J; Rao V; Tomlinson G; Delgado D; Keshavjee S; Juvet SC
    Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31164432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating anti-human leukocyte antigen IgM antibodies as a potential early predictor of allograft rejection and a negative clinical outcome after lung transplantation.
    Miyahara K; Miyoshi K; Kurosaki T; Otani S; Sugimoto S; Yamane M; Toyooka S
    Surg Today; 2022 Jan; 52(1):52-60. PubMed ID: 33961136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction.
    Pain M; Royer PJ; Loy J; Girardeau A; Tissot A; Lacoste P; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Dahan M; Knoop C; Botturi K; Pison C; Danger R; Brouard S; Magnan A;
    Am J Transplant; 2017 Jun; 17(6):1502-1514. PubMed ID: 27982503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor and recipient human leukocyte antigen-G polymorphisms modulate the risk of adverse immunologic events following lung transplantation.
    Riddell P; Ma J; Lazarte J; Birriel D; Ulahannan A; Ghany R; Delgado D; Rao V; Keshavjee S; Martinu T; Tikkanen J; Juvet SC
    Am J Transplant; 2023 Mar; 23(3):393-400. PubMed ID: 36695689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of HLA-G expression in lung transplant recipients.
    Brugière O; Thabut G; Pretolani M; Krawice-Radanne I; Dill C; Herbreteau A; Poras I; Moreau P; Colombat M; Danel C; Dehoux M; Fournier M; Carosella ED; Rouas-Freiss N
    Am J Transplant; 2009 Jun; 9(6):1427-38. PubMed ID: 19656137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
    Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V
    Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.
    Combs MP; Wheeler DS; Luth JE; Falkowski NR; Walker NM; Erb-Downward JR; Lama VN; Dickson RP
    Lancet Respir Med; 2021 Jun; 9(6):601-612. PubMed ID: 33460570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
    Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G.
    Brugière O; Mouren D; Trichereau J; Vallée A; Kuzniak I; Hirschi S; Renaud-Picard B; Reynaud-Gaubert M; Nieves A; Bunel V; Messika J; Demant X; Macey J; Le Pavec J; Dauriat G; Saint-Raymond C; Falque L; Mornex JF; Tissot A; Foureau A; Borgne Krams AL; Bousseau V; Magnan A; Picard C; Roux A; Carosella E; LeMaoult J; Rouas-Freiss N;
    J Heart Lung Transplant; 2022 May; 41(5):626-640. PubMed ID: 35181243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
    Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
    J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.
    Okushi Y; Okino K; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
    Clin Exp Nephrol; 2017 Oct; 21(5):932-940. PubMed ID: 28364323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.